Skip to main content
Have a personal or library account? Click to login
Identification of Serum Proteome in Children with Autism Spectrum Disorder Cover

Identification of Serum Proteome in Children with Autism Spectrum Disorder

By: ,   and    
Open Access
|May 2026

References

  1. Masi A., M.M. DeMayo, N. Glozier, A.J. Guastella. An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options. Neuroscience bulletin 2017; 33(2), 183–193.
  2. Maenner M.J., K.A. Shaw, J. Baio, A. Washington, M. Patrick, et al. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2016. MMWR Surveill Summ, 2020; 69(4):1–12.
  3. Tordjman S., E. Somogyi, N. Coulon, S. Kermarrec, D. Cohen, et al. Gene × environment interactions in autism spectrum disorders: Role of epigenetic mechanisms. Front Psychiatry. 2014; 4:5:53.
  4. Kaur K., V. Chauhan, F. Gu, A. Chauhan Bisphenol A induces oxidative stress and mitochondrial dysfunction in lymphoblasts from children with autism and unaffected siblings. Free Radic Biol Med. 2014; 76:25–33.
  5. Fernell E., M.A. Eriksson, C. Gillberg. Early diagnosis of autism and impact on prognosis: A narrative review. Clin Epidemiol. 2013; 5:33–43.
  6. Brett D., F. Warnell, H. McConachie, J.R. Parr. Factors Affecting Age at ASD Diagnosis in UK: No Evidence that Diagnosis Age has Decreased Between 2004 and 2014. J Autism Dev Disord. 2016; 46(6):1974–1984.
  7. Gurrieri F. Working up autism: The practical role of medical genetics. Am J Med Genet C Semin Med Genet. 2012; 160C (2):104–110.
  8. Skafidas E., R. Testa, D. Zantomio, G. Chana, I.P. Everall, et al. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol Psychiatry. 2014; 19(4):504–510.
  9. An D., X. Wei, H. Li, H. Gu, T. Huang, et al. (2015) Identification of PCSK9 as a novel serum biomarker for the prenatal diagnosis of neural tube defects using iTRAQ quantitative proteomics. Sci Rep. 2015; 5:17559.
  10. Kuleshov M.V., M.R. Jones, A.D. Rouillard, N.F. Fernandez, Q. Duan, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016; 44(W1):W90–W97.
  11. Woods A.G., I. Sokolowska, R. Taurines, M. Gerlach, E. Dudley, et al. Potential biomarkers in psychiatry: Focus on the cholesterol system. J Cell Mol Med. 2012; 16(6):1184–95.
  12. Corbett B.A., A.B. Kantor, H. Schulman, W.L. Walker, L. Lit, et al. A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol Psychiatry 2007; 12(3):292–306.
  13. Yang J., Y. Chen, X. Xiong, X. Zhou, L. Han, et al. Peptidome Analysis Reveals Novel Serum Biomarkers for Children with Autism Spectrum Disorder in China. Proteomics - Clin Appl. 2018; 12(5):1–30.
  14. Nadeem R., T. Hussain, H. Sajid. C reactive protein elevation among children or among mothers‘ of children with autism during pregnancy, a review and meta-analysis. BMC Psychiatry 2020; 20(1):251.
  15. Kwiatkowski A.V., F.B. Gertler, J.J. Loureiro Function and regulation of Ena/VASP proteins. Trends Cell Biol. 2003; 13(7):386–392.
  16. Basu S., R. Lamprech. The role of actin cytoskeleton in dendritic spines in the maintenance of long-term memory. Front Mol Neurosci, 2018; 11:143.
  17. Michaelsen-Preusse K., S. Zessin, G. Grigoryan, F. Scharkowski, J. Feuge, et al. Neuronal profilins in health and disease: Relevance for spine plasticity and Fragile X syndrome. Proc Natl Acad Sci USA 2016; 113(12):3365–3370.
  18. Gardner J.F., T.D. Cushio, G. Niotakis, H.E. Olson, P.E. Grant, et al. Clinical and functional characterization of the recurrent TUBA1A p.(ARG2HIS) mutation. Brain Sci. 2018; 8(8):145.
  19. Pinto-Costa R., S.C. Sousa, S.C. Leite, J. Nogueira-Rodrigues, T.F. da Silva, et al. Profilin 1 delivery tunes cytoskeletal dynamics toward CNS axon regeneration. J Clin Invest. 2020; 130(4):2024–40.
  20. Shen L., K. Zhang, C. Feng, Y. Chen, S. Li, et al. (2018) iTRAQ-Based Proteomic Analysis Reveals Protein Profile in Plasma from Children with Autism. Proteomics - Clin Appl. 2018; 12(3):1–45.
  21. Wei H., Y. Ma, J. Liu, C. Ding, F. Hu, et al. Proteomic analysis of cortical brain tissue from the BTBR mouse model of autism: Evidence for changes in STOP and myelin-related proteins. Neuroscience 2016; 312:26–34.
  22. El Gohary T.M., N.A. El Aziz, M. Darweesh, E.S. Sadaa Plasma level of transforming growth factor β 1 in children with autism spectrum disorder. Egypt J Ear, Nose, Throat Allied Sci, 2015; 16(1):69–73.
  23. Condomitti G., J. De Wit Heparan sulfate proteoglycans as emerging players in synaptic specificity. Front Mol Neurosci 2018; 11:1–14.
Language: English
Page range: 85 - 92
Published on: May 14, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2026 T N Popov, S D Minchev, I T Vachev, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.